Chugai Pharmaceutical : Organizational and Personnel Changes

Organizational and Personnel Changes

TOKYO, November 25, 2024 -- Chugai Pharmaceutical Co., Ltd.(TOKYO: 4519) announced the following organizational and personnel changes, effective January 1, 2025.

[Details of Organizational Changes]

1. Introduction of disease area-based branches in Marketing & Sales Div.

To strengthen and unify the head office functions of formulating disease area strategies with the Regional Management Offices functions of addressing challenges close to medical sites, we will reorganize the "branches" and "sections" of regional offices and transfer certain functions to the head office. This will establish a new sales structure to realize truly patient-centric healthcare.

Specifically, by dividing each branch into oncology and specialty areas, we will expand the facilities and areas covered by each branch, enabling them to plan and execute strategies with a broader perspective. By enhancing the organization's expertise, we aim to build stronger relationships of trust with healthcare professionals through in-depth discussions.

• Introduce disease area-based branches for oncology and specialty within Regional Management Offices.
• Consolidate branches and sections in accordance with personnel allocation aligned with disease area strategies.
• Dissolve Area Strategy Execution Group, and its subordinate Oncology/Specialty Therapeutic Area Sects. and Solution Sect. within Regional Management Offices. Consequently, the functions of the specialized MRs in therapeutic area sections will be integrated into Oncology/Specialty Marketing Depts. The Medical Network Liaison/Team Healthcare Promotion functions of Solution Sect. will be integrated into Customer Solution Dept.
• Newly establish Business Solutions Consolidated Management Sect. within Regional Management Offices, strengthening data analysis and digital transformation functions to execute strategies.

2. Reorganization of the Digital Transformation Unit

The organizational structure for developing and executing company-wide digital strategies, currently handled by Digital Strategy Dept., and the planning, building, and operating information systems, currently managed by IT Solution Dept., will be reorganized into strategies planning and execution functions. By consolidating the functions of both current departments, we aim to accelerate co-creation with various functions and establish a structure that can effectively and flexibly execute the shift to digital that creates even more value.

• Reorganize the roles of the Digital Strategy Dept. and IT Solution Dept., and rename them to Digital Strategy Planning Dept. and Digital Solution Dept.

[Details of Personnel Changes]

Directors

Name	New Responsibilities	Current Responsibilities
Hitoshi Iikura	Director, Executive Vice President	Director, Executive Vice President
	Supervisory responsibility for	Supervisory responsibility for
	Research, Translational Research,	Research, Translational Research
	Clinical Development and Special	and Clinical Development
	Mission for CVF	Head of Translational Research Div.
	Head of Translational Research Div.
Executive Officers
Name	New Responsibilities	Current Responsibilities
Tetsuya	Executive Vice President	Executive Vice President
Yamaguchi	Special Mission for CEO	Supervisory responsibility for PHC
		Solution, Partnering and Special
		Mission for CVF
		Head of PHC Solution Unit
		In charge of Partnering Dept.
Shinji Hidaka	Executive Vice President	Executive Vice President
	Supervisory responsibility for	Supervisory responsibility for
	Marketing & Sales, Drug Safety,	Marketing & Sales, Drug Safety,
	Medical Affairs, PHC Solution and	and Medical Affairs
	Special Mission for Overseas
	Marketing
Tsukasa Kusano	Executive Vice President	Executive Vice President
	Supervisory responsibility for	Supervisory responsibility for
	Project & Lifecycle Management	Project & Lifecycle Management
	and Partnering	Head of Project & Lifecycle
	Head of Project & Lifecycle	Management Unit
	Management Unit
	In charge of Partnering Dept.
		2 / 5

Kaori Ouchi	Executive Vice President	Executive Vice President
	Supervisory responsibility for Risk	Supervisory responsibility for Risk
	Management, Compliance, Quality	Management, Compliance, Quality
	& Regulatory Compliance,	& Regulatory Compliance,
	Pharmaceutical Technology and	Pharmaceutical Technology and
	Manufacturing Technology	Manufacturing Technology
	In charge of Risk & Compliance
	Dept.
Masayoshi	Vice President	Vice President
Higuchi	Special Mission for CEO	Head of Quality & Regulatory
		Compliance Unit
		In charge of Risk & Compliance
		Dept.
Division Heads and Department Heads
Name	New Responsibilities	Current Responsibilities
Shin Yoshida	Head of Quality & Regulatory	Head of Drug Safety Coordination
	Compliance Unit	Dept., Drug Safety Div.
Takuya Nakagawa	Head of PHC Solution Unit	Head of Specialty Medical Science
		Dept., Medical Affairs Div.
Takashi Okamoto	Deputy Head of Project & Lifecycle	President of Chugai Pharma Taiwan
	Management Unit and Head of	Ltd.
	Marketing & Sales Planning Dept.
Michiaki Tanaka	Head of R&D Portfolio Management	Head of Project Planning &
	Dept., Project & Lifecycle	Coordination Dept., Translational
	Management Unit	Research Div.
Kazumitsu	Head of Digital Strategy Planning	Head of Digital Strategy Dept.,
Kanatani	Dept., Digital Transformation Unit	Digital Transformation Unit
Keisuke Ohara	Head of Digital Solution Dept.,	Head of IT Solution Dept., Digital
	Digital Transformation Unit	Transformation Unit
Masaki Honda	Head of Safety and Bioscience	Head of Safety Management
	Research Dept. and Head of Safety	Group, Safety and Bioscience
	Management Group, Safety and	Research Dept., Translational
	Bioscience Research Dept.,	Research Div. and Technology
	Translational Research Div.	Partnering Group, Partnering Dept.
Keisuke Akada	Head of Project Planning &	CPE Development Division, Chugai
	Coordination Dept., Translational	Pharma Europe Ltd.
	Research Div.

3 / 5

Shinji Yamakido	Head of Clinical Strategy and	Deputy Head (Clinical Strategy and
	Resource Management Dept.,	Risk Management) of Clinical
	Clinical Development Div.	Strategy and Resource
		Management Dept., Clinical
		Development Div.
Takatoshi Ozawa	Head of Specialty Clinical	Head of Specialty Clinical
	Development Dept., Clinical	Development 1 Group 1, Specialty
	Development Div.	Clinical Development Dept., Clinical
		Development Div.
Tadanobu	Head of Analytical Development	Deputy Head (Chemical Product
Nakayama	Dept. and Deputy Head (Chemical	Analysis) of Analytical Development
	Product Analysis) of Analytical	Dept., Pharmaceutical Technology
	Development Dept.,	Div.
	Pharmaceutical Technology Div.
Shiho Fujioka	Head of Drug Safety Coordination	Head of PV Process Management
	Dept., Drug Safety Div.	Group, Drug Safety Coordination
		Dept., Drug Safety Div.
Yoshimasa	Head of Oncology Medical Science	Head of Oncology Strategy Group
Hanada	Dept., Medical Affairs Div.	2, Oncology Lifecycle Management
		Dept., Project & Lifecycle
		Management Unit
Haruko	Head of Specialty Medical Science	Deputy Head (Oncology Area
Yamaguchi	Dept., Medical Affairs Div.	Regional Manager) of Oncology
		Medical Science Dept., Medical
		Affairs Div.
Takahiko Inoue	Head of Specialty Marketing Dept.,	Head of Tokai & Hokuriku Regional
	Marketing & Sales Div.	Management Office, Marketing &
		Sales Div.
Chieko Takahashi	Head of Marketing & Sales Human	Head of Human Resources
	Resources Management Dept.,	Planning Group, Marketing & Sales
	HRBP of Marketing & Sales Div.	Human Resources Management
		Dept., Marketing & Sales Div. and
		Human Resources Management
		Dept.
Masaki	Head of Kita-Nippon Regional	Head of Chiba Branch, Kanto-
Matsumoto	Management Office, Marketing &	Minami Regional Management
	Sales Div.	Office, Marketing & Sales Div.
Yasuhiro Tehara	Head of Kanto-Kita Koshinetsu	Head of Saitama Branch, Kanto-
	Regional Management Office,	Kita & Koshinetsu Regional
	Marketing & Sales Div.	Management Office, Marketing &
		Sales Div.
		4 / 5

Tomoyuki Iwai	Head of Kanto-Minami Regional	Head of Area Strategy Execution
	Management Office, Marketing &	Group, Kanto-Kita & Koshinetsu
	Sales Div.	Regional Management Office,
		Marketing & Sales Div.
Hiroshi Koyama	Head of Tokai Hokuriku Regional	Head of Hokuriku Branch, Tokai &
	Management Office, Marketing &	Hokuriku Regional Management
	Sales Div.	Office, Marketing & Sales Div.
Yukito Hosono	Head of Kansai Regional	Head of Tokyo Branch 1, Kanto-
	Management Office, Marketing &	Minami Regional Management
	Sales Div.	Office, Marketing & Sales Div.
Hiroyuki	Head of Kyushu Regional	Head of Shizuoka Branch, Tokai &
Matsuyama	Management Office, Marketing &	Hokuriku Regional Management
	Sales Div.	Office, Marketing & Sales Div.
Group Companies
Name	New Responsibilities	Current Responsibilities
Hidenari Yamada	Head of Utsunomiya Plant, Chugai	Head of R&D Portfolio Management
	Pharma Manufacturing Co., Ltd.	Dept., Project & Lifecycle
		Management Unit
	###

5 / 5